Skip to content

The screening of serum biomarkers in diabetes.

The screening of serum biomarkers in diabetes.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800014301
Enrollment
Unknown
Registered
2018-01-04
Start date
2018-02-26
Completion date
Unknown
Last updated
2018-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes

Interventions

Patients cohort:no intervention

Sponsors

Beijing Shijitan hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients consistent with diagnostic criteria of diabetes (fasting glucose > 7.0 mmol/L); 2. Patients consistent with diagnostic criteria of prediabetes (1. IFG: FPG 5.6 ? 6.9 mmol/L or 2. IGT: OGTT 2h PG7.8 - 11.0 mmol/L or 3. A1C 5.7 - 6.4%); 3. Patients aged between 30 and 70 years old; 4. Patients signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with following cerebrocardiovascular event: cerebrovascular accidents, myocardial infarction or heart failure within 6 months; severe organic cardiopathy; giant or dissecting aneurysms; angina pectoris; atrioventricular block over II degree and sicksinussyndrome; 2. Patients with impaired function of liver and kidney (AST and ALT = 1.5 times of upper limit of normal value; Cr > normal value; positive urine protein; non-menses); 3. Fasting triglyceride = 10mmol/L; 4. Patients with other endocrine diseases, autoimmune disorders, tumor or severe lethal diseases administered with glucocorticoid, antibiotics or Chinese herbs; 5. Women in pregnancy or to be pregnant; women in lactation; 6. Patients with psychosis or insight; patients who are unable to express exact intention or dont cooperate (dont obey the regulation of diet and medication); 7. Patients participating or participated other clinical trials within 4 weeks; 8. Allergic patients.

Design outcomes

Primary

MeasureTime frame
Serum metabolites;

Countries

China

Contacts

Public ContactDan Yan

Beijing Shijitan Hospital, Capital Medical University

yd277@126.com+86 13488678873

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026